ERASCA INC's ticker is and the CUSIP is 29479A108. A total of 88 filers reported holding ERASCA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $107,294 | +154.9% | 54,464 | +257.2% | 0.00% | – |
| Q2 2023 | $42,087 | -95.0% | 15,249 | -94.6% | 0.00% | – |
| Q1 2023 | $844,498 | +1559.4% | 280,564 | +2276.1% | 0.00% | – |
| Q4 2022 | $50,892 | -52.0% | 11,808 | -12.9% | 0.00% | – |
| Q3 2022 | $106,000 | +63.1% | 13,557 | +16.9% | 0.00% | – |
| Q2 2022 | $65,000 | -59.4% | 11,599 | -37.8% | 0.00% | – |
| Q1 2022 | $160,000 | – | 18,658 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AH Equity Partners Bio II, L.L.C. | 2,500,000 | $19,500,000 | 13.59% |
| ARCH Venture Management, LLC | 11,055,554 | $86,233,000 | 11.18% |
| EDBI Pte Ltd | 888,888 | $6,933,000 | 7.30% |
| Cormorant Asset Management, LP | 10,505,554 | $81,943,000 | 5.73% |
| AH Equity Partners V, L.L.C. | 50,000 | $390,000 | 2.53% |
| AH Equity Partners LSV II, L.L.C. | 312,500 | $2,438,000 | 2.18% |
| PFM Health Sciences, LP | 7,264,981 | $56,667,000 | 2.05% |
| Artal Group S.A. | 3,172,221 | $24,743,000 | 1.06% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 472,472 | $3,685,000 | 0.75% |
| EcoR1 Capital, LLC | 678,441 | $5,292,000 | 0.16% |